Bonjesta Tablet, Extended Release
Product Images NDC 55494-120

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bonjesta (NDC 55494-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Duchesnay Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label-outside Front Cover With Imprint Area For Lot & Expiry (Bottle Label 1)

Packaging label for BONJESTA extended-release tablets 20 mg/20 mg (doxylamine succinate and pyridoxine hydrochloride) by Duchesnay USA, Inc. The label includes dosage instructions, storage conditions, and a barcode. It indicates a 60-count bottle and provides warnings about tablet use.*

FDA Label Image

Bottle Label – Inside Cover (Bottle Label Inside)

Label for BONJESTA extended-release tablets containing doxylamine succinate and pyridoxine hydrochloride, each tablet 20 mg/20 mg. The label includes dosage instructions, storage conditions, cautionary notes, and is marked Rx only. Manufactured by Duchesnay USA, Inc., it shows the NDC 55494-120-60 and indicates a package of 60 extended-release tablets.*

FDA Label Image

Halal Symbol (Halal)

Box packaging of BONJESTA 20 mg/20 mg extended-release oral tablets, containing doxylamine succinate and pyridoxine hydrochloride. The label shows the brand name BONJESTA prominently with dosage strengths, identifies the form as extended-release tablets, includes the labeler Duchesnay USA, Inc., and provides usage information and warnings typically found on prescription drug cartons.*

FDA Label Image

Kosher Symbol (Kosher)

The BONJESTA carton label shows the proprietary name BONJESTA and the generic names doxylamine succinate and pyridoxine hydrochloride. It is an extended-release oral tablet. The label indicates a strength of 20 mg/1 mg. The labeler is Duchesnay USA, Inc., and the product NDC is 55494-120.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of the active ingredients doxylamine succinate and pyridoxine hydrochloride as shown in the Bonjesta product labeling.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of pyridoxine hydrochloride, showing a substituted pyridine ring with hydroxyl groups and a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.